Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Research & Development: 2020-2024

Historic Research & Development for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $3.5 million.

  • iSpecimen's Research & Development fell 26.98% to $551,104 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 27.13%. This contributed to the annual value of $3.5 million for FY2024, which is 1.03% down from last year.
  • According to the latest figures from FY2024, iSpecimen's Research & Development is $3.5 million, which was down 1.03% from $3.6 million recorded in FY2023.
  • iSpecimen's Research & Development's 5-year high stood at $3.6 million during FY2023, with a 5-year trough of $1.5 million in FY2020.
  • Moreover, its 3-year median value for Research & Development was $3.5 million (2024), whereas its average is $3.3 million.
  • In the last 5 years, iSpecimen's Research & Development surged by 44.53% in 2022 and then fell by 1.03% in 2024.
  • Over the past 5 years, iSpecimen's Research & Development (Yearly) stood at $1.5 million in 2020, then climbed by 25.42% to $1.8 million in 2021, then skyrocketed by 44.53% to $2.7 million in 2022, then soared by 34.28% to $3.6 million in 2023, then declined by 1.03% to $3.5 million in 2024.